ETR vs SCNI · P/E 28, rev $12.95B vs P/E 0.2, rev $1.3M
Entergy Corporation (ETR) versus Scinai Immunotherapeutics Ltd (SCNI) — a side-by-side from cached financials, not a winner call.
Entergy Corporation (ETR) is a utilities - regulated electric company listed on US.
Scinai Immunotherapeutics Ltd (SCNI) is a biotechnology company listed on NASDAQ.
Latest reported ETR revenue for 2025-12-31 was $12.95B. Net income was $1.77B. Revenue was up 9.0% from 2024-12-31 to 2025-12-31. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
Latest reported SCNI revenue for 2025-12-31 was $1.3M. Net income was -$8.3M. Revenue was up 99.2% from 2024-12-31 to 2025-12-31. SCNI currently screens at market cap $1.8M and trailing P/E 0.2.
ETR currently screens at market cap $50.71B and trailing P/E 28.3. SCNI currently screens at market cap $1.8M and trailing P/E 0.2.
Not investment advice. Open the ETR and SCNI stock pages for the full models.
Not investment advice.